Hengrui and Kailera's Oral GLP-1 Successfully Surpasses Late-Stage Trial in China While US Outcomes Remain Awaited

Hengrui and Kailera’s Oral GLP-1 Successfully Surpasses Late-Stage Trial in China While US Outcomes Remain Awaited